A Fresh Take
Insights on M&A, litigation, and corporate governance in the US.
Subscribe to receive the latest posts direct to your inbox.Subscribe
You’ve been warned – FTC’s first merger closing statement in over three years sends a reminder to companies that antitrust is only one consideration
In a rare move on February 27, 2023, the Federal Trade Commission (FTC) issued its first statement akin to a closing statement since 2019. The FTC’s statement was, however, lukewarm. Its focus was war...
Bridging Valuation Gaps in Public M&A in the Pharma, Biotech, and Other Life Sciences Industries
Acquisitions of public companies in pharma, biotech, and other life sciences industries are increasingly using deal structures designed to bridge valuation gaps between buyers and target companies. Ev...